7.01.20
6 min. Read

What Otsuka bid for Proteus. Important DTx study begins.

Issue 059.

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote about a secret JNJ acquisition and wondered if the VA confirmed that Google/Nest health project I wrote about last year. Next week I am open to ideas -- what should E&O dig into? Here's what's happening this week:

  • The 4th of July holiday is coming up this weekend in the USA, so E&O is coming at you a bit earlier in the week.
  • The FDA's digital health team is on a hiring spree. Is this prep for Pre-Cert? More here.
  • Still thinking about Apple adding sleep tracking to the Watch. I think it is a fair bet that Apple moves deeper into sleep health, into quasi-diagnostic territory as they did with AFib. First, their heart rate sensor was just for exercising, remember. I could see their sleep efforts evolving quickly and moving into FDA-regulated territory for a huge,

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Mahana Therapeutics’ insolvency. FDA clears Happy Ring (Tinder founder’s smart ring)
10.04.24
5 min. Read
Flashback: How Proteus Digital Health’s outcomes-based pricing worked for Tennessee Medicaid
9.20.24
5 min. Read
Are the Digital Mental Health Treatment G Codes necessary? Or RTM dupes?
7.12.24
7 min. Read
Which PDTs are still around? New bill in Congress.
6.28.24
10 min. Read
FDA OKs Alivecor (12L?), Akili OTC. Oui eyes obesity.
6.21.24
5 min. Read
Digging into the Akili-Virtual Therapeutics deal
5.31.24
10 min. Read
CMS questions MedRhythms on InTandem
5.17.24
5 min. Read
MedRhythms-Alexion. Akili RCT for OTC.
4.26.24
6 min. Read
Hints about Otsuka’s commercialization plan for Rejoyn
4.16.24
6 min. Read
Better Therapeutics shuts down. Mahana-Cara Care
3.15.24
5 min. Read
  • First
  • Previous
  • 1 of 21
  • Next
  • Last